Visual snow (VS) is a neurologic condition consisting of a constant positive visual disturbance described as “static” with diagnosis requiring exclusion of competing neurologic and ophthalmologic disorders. The authors describe the first case of visual snow-like symptoms in a patient following coronavirus disease 2019 (COVID-19) infection. He was found to have a transient subtle mild inflammatory reaction in the vitreous and optic nerve edema which resolved, but the VS persisted. Our findings suggest that COVID-19 may precipitate a transient autoimmune response in some patients with resultant ocular inflammation as well as long-term symptoms of VS. This has potential implications for the understanding and treatment of complications related to COVID-19 and in VS.
Purpose: To report a case of peripheral elevated lesions mimicking retinal detachment which were ultimately ascertained to be giant pars plana cysts through ophthalmoscopy with scleral depression. Methods: This was a case report documented with ophthalmoscopy and Optos imaging. Results: Patient initially referred for assessment of bilateral retinal detachment was found by careful ophthalmoscopy with scleral depression to have bilateral giant pars plana cysts with no frank retinal breaks. Conclusion: Large pars plana cysts may mimic retinal detachment or other peripheral retinal pathology. The lesions in question were found to originate from the pars plana and overhang the retina. No frank retinal breaks or associated rhegmatogenous retinal detachments were noted in either eye. Ophthalmoscopy with a complete scleral depressed exam allowed for the differentiation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.